Search

Search Constraints

You searched for: Author/Creator Suehiro, Youko

Search Results

1. A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma. Issue 7 (4th June 2021)

2. Clinical outcomes of a novel therapeutic vaccine with Tax peptide‐pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study. (22nd January 2015)

3. Clinical significance of the immunoglobulin G heavy‐chain repertoire in peripheral blood mononuclear cells of adult T‐cell leukaemia–lymphoma patients receiving mogamulizumab. (10th October 2021)

4. Clinical significance of tryptophan catabolism in follicular lymphoma. Issue 5 (29th September 2020)

5. Clinical significance of tryptophan catabolism in Hodgkin lymphoma. Issue 1 (29th November 2017)

6. Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105). Issue 9 (31st July 2022)

7. Follow‐up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: impact on allogeneic haematopoietic stem cell transplantation. (7th February 2018)

8. Heterochronous occurrence of microsatellite instability in multiple myeloma – an implication for a role of defective DNA mismatch repair in myelomagenesis. Issue 10 (3rd October 2018)

10. Parsaclisib in Japanese patients with relapsed or refractory B‐cell lymphoma (CITADEL‐111): A phase Ib study. Issue 5 (15th March 2022)